Impairment of PMP22 transgenic Schwann cells differentiation in culture: implications for Charcot-Marie-Tooth type 1A disease
- 30 June 2004
- journal article
- research article
- Published by Elsevier BV in Neurobiology of Disease
- Vol. 16 (1), 263-273
- https://doi.org/10.1016/j.nbd.2004.02.007
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- Alterations in the Arf6-regulated plasma membrane endosomal recycling pathway in cells overexpressing the tetraspan protein Gas3/PMP22Journal of Cell Science, 2003
- Exposure at the Cell Surface Is Required for Gas3/PMP22 To Regulate Both Cell Death and Cell Spreading: Implication for the Charcot–Marie–Tooth Type 1A and Dejerine–Sottas DiseasesMolecular Biology of the Cell, 2000
- GTPases and Phosphatidylinositol 3-Kinase Are Critical for Insulin-like Growth Factor-I-mediated Schwann Cell MotilityOnline Journal of Public Health Informatics, 2000
- Rho-dependent Regulation of Cell Spreading by the Tetraspan Membrane Protein Gas3/PMP22Molecular Biology of the Cell, 1999
- Pathogenesis of Charcot–Marie–Tooth 1A (CMT1A) neuropathyTrends in Neurosciences, 1998
- Improved culture methods to expand schwann cells with altered growth behaviour from CMT1A patientsGlia, 1998
- Schwann cell differentiation in Charcot-Marie-Tooth disease type 1A (CMT1A): normal number of myelinating Schwann cells in young CMT1A patients and neural cell adhesion molecule expression in onion bulbsActa Neuropathologica, 1997
- Apoptotic phenotype induced by overexpression of wild-type gas3/PMP22: its relation to the demyelinating peripheral neuropathy CMT1A.Journal of Bone and Joint Surgery, 1995
- Movements of the Schwann cell nucleus implicate progression of the inner (axon-related) Schwann cell process during myelination.The Journal of cell biology, 1989
- Studies on cultured rat Schwann cells. I. Establishment of purified populations from cultures of peripheral nerveBrain Research, 1979